Page last updated: 2024-10-31

modafinil and Autoimmune Disease

modafinil has been researched along with Autoimmune Disease in 2 studies

Modafinil: A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.
modafinil : A racemate comprising equimolar amounts of armodafinil and (S)-modafinil. A central nervous system stimulant, it is used for the treatment of sleeping disorders such as narcolepsy, obstructive sleep apnoea, and shift-work sleep disorder. The optical enantiomers of modafinil have similar pharmacological actions in animals.
2-[(diphenylmethyl)sulfinyl]acetamide : A sulfoxide that is dimethylsulfoxide in which two hydrogens attached to one of the methyl groups are replaced by phenyl groups, while one hydrogen attached to the other methyl group is replaced by a carbamoyl (aminocarbonyl) group.

Research Excerpts

ExcerptRelevanceReference
"Narcolepsy is an emblematic, unique disease within sleep disorders that is characterised by excessive daytime sleepiness, cataplexy and other abnormal manifestations of REM sleep."2.48[Diagnostic and therapeutic update in narcolepsy]. ( Santamaria-Cano, J, 2012)
"Fatigue is among the most common, yet least understood, symptoms of multiple sclerosis (MS) [1."2.41Fatigue in multiple sclerosis. ( Christodoulou, C; Krupp, LB, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Santamaria-Cano, J1
Krupp, LB1
Christodoulou, C1

Reviews

2 reviews available for modafinil and Autoimmune Disease

ArticleYear
[Diagnostic and therapeutic update in narcolepsy].
    Revista de neurologia, 2012, May-21, Volume: 54 Suppl 3

    Topics: Adolescent; Adult; Age of Onset; Animals; Autoimmune Diseases; Benzhydryl Compounds; Cataplexy; Chil

2012
Fatigue in multiple sclerosis.
    Current neurology and neuroscience reports, 2001, Volume: 1, Issue:3

    Topics: Amantadine; Autoimmune Diseases; Benzhydryl Compounds; Brain; Case Management; Central Nervous Syste

2001